Search for a trial

A single-center randomized, adaptive, investigator/participant blind, single oral ascending dose, placebo-controlled Phase I study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7189752 in healthy male participants.

The purpose of this study is to investigate how safe the new compound RO7189752 is and how well it is tolerated when it is administered as a drink to healthy male volunteers. RO7189752 has not been administered to humans before. It has been…